A commonly accepted pivotal mechanism in fluid volume and blood pressure regulation is the parallel relationship between body Na + and extracellular fluid content. 1 To maintain blood pressure homeostasis, body fluid volume, and thereby body Na + content, has to be maintained within very narrow limits. Several recent studies in humans have, however, shown that a considerable amount of Na + is retained or removed from the subjects' bodies without corresponding water retention or loss 2-5 that would have been predicted if the extracellular fluid volume was determined by the amount of body Na + only. These observations suggest that Na + could be stored somewhere in the body without commensurate water retention, and thereby be inactive from a fluid balance viewpoint, for example, 6 also implying that unidentified extrarenal, tissue-specific regulatory mechanisms might control the release and storage of Na + from a kidney-independent reservoir. Later studies have indicated that skin might serve as a major Na + reservoir, for example, 7-10 again suggesting that there might not be strict isotonicity of all body fluids, and that skin electrolyte concentrations do not necessarily equilibrate with blood electrolytes. One consequence of such electrolyte accumulation in excess of water would be that it might cause local hypertonicity. Indeed, using vapor pressure osmometry, we recently demonstrated that Na + accumulation in skin as a consequence of feeding rats a high-salt diet (HSD) results in a tissue that is hyperosmotic relative to plasma.
A commonly accepted pivotal mechanism in fluid volume and blood pressure regulation is the parallel relationship between body Na + and extracellular fluid content. 1 To maintain blood pressure homeostasis, body fluid volume, and thereby body Na + content, has to be maintained within very narrow limits. Several recent studies in humans have, however, shown that a considerable amount of Na + is retained or removed from the subjects' bodies without corresponding water retention or loss [2] [3] [4] [5] that would have been predicted if the extracellular fluid volume was determined by the amount of body Na + only. These observations suggest that Na + could be stored somewhere in the body without commensurate water retention, and thereby be inactive from a fluid balance viewpoint, for example, 6 also implying that unidentified extrarenal, tissue-specific regulatory mechanisms might control the release and storage of Na + from a kidney-independent reservoir. Later studies have indicated that skin might serve as a major Na + reservoir, for example, [7] [8] [9] [10] again suggesting that there might not be strict isotonicity of all body fluids, and that skin electrolyte concentrations do not necessarily equilibrate with blood electrolytes. One consequence of such electrolyte accumulation in excess of water would be that it might cause local hypertonicity. Indeed, using vapor pressure osmometry, we recently demonstrated that Na + accumulation in skin as a consequence of feeding rats a high-salt diet (HSD) results in a tissue that is hyperosmotic relative to plasma. 11 Because of the demonstration of its role in salt storage and buffering discussed above, the skin is a potential actor in blood pressure regulation. Mice and rats fed HSD develop hypertension and have a hyperplastic lymphatic capillary network in the skin induced by VEGF (vascular endothelial growth factor)-C secreted by mononuclear phagocyte system (MPS) cells. 11, 12 Blocking the ability for lymphangiogenesis results in an increased blood pressure response to salt loading. 11 An unresolved and central question is whether such HSD-induced lymphangiogenesis results in increased lymph flow, that is, whether the vessels are functional. We, therefore, asked whether the Na + concentration-dependent lymph vessel hyperplasia has functional importance. To this end, we decided to assess the importance of lymphatic vessel phenotype for fluid drainage, and whether lymph flow is actually increased in rats with hypertension induced by HSD or deoxycorticosterone (DOCA) treatment using a recently developed optical imaging technique. 13 We also assessed how skin lymphatic collectors, studied ex vivo, would respond to elevated Na + . Moreover, because Na + also seem to accumulate in skeletal muscle in hypertensive patients, 14 we asked if such accumulation also influenced fluid drainage in muscle, and developed a positron emission tomography/computed tomography (PET/CT) method to be able to assess lymph flow in deeper structures.
Collectively, the present results indicate that the newly formed lymphatics induced by salt accumulation either by HSD or DOCA are functional. Moreover, our data suggest that existing and newly formed lymph vessels contribute to blood pressure control and to the previously observed attenuation of the rise in blood pressure in models of salt-sensitive hypertension.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Ethical Approval
All animal experiments were conducted in accordance with the regulations of the Norwegian State Commission for Laboratory Animals, harmonized to be in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes and Council of Europe (ETS 123), and with approval from the AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) International Accredited Animal Care and Use Program at University of Bergen. All mouse protocols were approved by the University of Missouri Animal Care and Use Committee and conformed to the US Public Health Service policy for the humane care and use of laboratory animals (PHS Policy, 1996).
Animals
We used mice and rats. The animals were of male sex only because background data for the hypothesis to be tested were derived from this sex only. Mice (C57Bl/6), weighing between 18 and 22 g, were obtained from Jackson Laboratories (JAX, United States) and used for isolation of skin lymphatic collecting vessels (Major Resources  Table in the online-only Data Supplement). NTac Sprague Dawley rats were from Møllegaard Breeding Colony, Skensved, Denmark, weighing between 150 to 200 g at the start of the experiment. The rats were randomly assigned into 3 groups with different diet regimes; group low-salt diet (LSD) received low-salt chow (<0.1% NaCl) and tap water; group HSD received high-salt chow (8% NaCl) and 1% saline drinking water; group DOCA received low-salt chow and 1% saline drinking water after subcutaneous implantation of a DOCA acetate tablet (100 mg/pellet, Innovative Research of America) in the neck region. In a separate set of experiments, the 3 different diet groups were treated with intraperitoneal injections of 1 mL clodronate liposomes (5 mg/mL Clodrosome, Encapsula Nanosciences) every fourth day, at day 0, 4, 8, and 12.
After 2 weeks on a diet, blood pressure was measured in all groups with a noninvasive tail-cuff system (CODA-6, Kent Scientific, Torrington, CT), and further experiments conducted as described below.
During experiments, the rats were either anesthetized with 3% isoflurane (DOCA pellet implantation, optical imaging, and extravasation) or 2% sevoflurane (PET/CT) both in 100% O 2 . The body temperature was maintained at 37°C while under anesthesia. The experiments were terminated by excising the heart while under deep anesthesia.
Mice were anesthetized with an intraperitoneal injection of sodium pentobarbital (60 mg/kg). After anesthesia, an incision was made near the midline of the lower back, and the skin covering the left rear flank was retracted to the side. A segment of the afferent lymphatic draining the skin and feeding into the inguinal lymph node fat pad was cleared of loose connective tissue and excised.
Preparation of Radiolabeled Probes
Human serum albumin (HSA; Albunorm, Octopharma, 200 mg/mL) was labeled with 125 I and 131 I (for extravasation studies) or 124 I (for PET/CT) by Iodo-Gen as described in detail previously.
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Albumin Extravasation
Blood-to-tissue clearance of albumin in hind paw skin and thigh muscle was determined as the difference between the 35 and 5-minute plasma equivalent space of 125 I-HSA and 131 I-HSA, respectively, as described in detail elsewhere. 16 
Optical Imaging
To assess lymph flow in skin, we monitored the depot clearance of an intradermally injected near-infrared macromolecular tracer with time by optical imaging as described in detail previously.
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PET/CT Scanning
To assess lymph flow in muscle, we developed a PET/CT method.
124 I-HSA (3 µL) was injected into a thigh muscle with a graded Hamilton syringe. PET and CT scans (small-animal PET/CT, NanoScan PC PET/CT; Mediso Ltd, Budapest, Hungary) were performed 1, 3, 5, 7, and 22-hour postinjection to determine the clearance of macromolecular tracer from the injected area. The rats were awake and freely moving in between scans to facilitate lymph flow. First, a CT scan was performed to obtain anatomic information and for attenuation correction, with the following acquisition parameters: helical scan, 70 kVp, 300 ms, projections: 360 and reconstructed using Shepp Logan filter. Directly thereafter, a 10 minutes per bed position PET scan was performed with acquisitions parameters as follows: field of view 9.6 cm in the axial direction and 10 cm in the transaxial direction, 1:5 coincidence mode and normal count rate mode. The body temperature was maintained at 37 degrees throughout the whole procedure. Reconstruction of the PET data was performed with 3D OSEM and 1:3 coincidence mode, no filtering, attenuation correction, decay correction, and normalization of detectors. The images were analyzed using Interview fusion software (version 2.02.029.2010 BETA) and a number of photon counts calculated for each region of interest. For the determination of removal rate constants (k), the natural logarithm of the fractional amount of counts remaining at the injection site was plotted against time. The resultant monoexponential curves were fitted with linear regression. The rate constant, k, for each animal was calculated as the slope of the curve, as described previously. 
Immunohistochemistry Paraffin Sections
Ears were fixed overnight in 4% PFA before paraffin embedding and sectioning. After deparaffinization, antigen retrieval was performed in Daco Target Retrieval solution pH 9 for 30 minutes at 98°C. Sections were blocked in horse serum and bovine serum albumin (BSA) for 30 minutes, before overnight incubation at 4°C with mouse anti-rat CD68 primary antibody (1:100, Abcam) in blocking solution (Major Resources Table in 
Contractility of Isolated Mouse Afferent Skin Lymphatics
The excised segment of afferent lymphatic was placed in 145 Na + Krebs solution +0.5% BSA, cleaned of fat and connective tissue, and cannulated at each end with a micropipette as described previously 17 (for composition of solutions used in contractility experiments; Major Resources Table in the online-only Data Supplement). Pipettes contained 145 Na + Krebs+0.5% BSA. The vessel, bath chamber, and pipette holders were mounted onto the stage of an inverted microscope and connected to independent pressure controllers. 18 The vessel equilibrated at 37°C for 60 to 90 minutes, at 3 cm H 2 O, with the bath was exchanged with 145 Na + Krebs solution (0.5 mL/min). Video and data acquisition were the same as described previously.
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Protocols Used in Contractility Assessment
Spontaneous contractions typically began within 15 minutes. Pressure was stepped through a physiological range of pressures, 0.5 to 10 cm H 2 O in a sequence of 3, 2, 1, 0.5, 1, 2, 3, 5, 8, and 10 cm H 2 O, with contractions recorded for 2 to 3 minutes at each pressure. Input and output pressures were equal at all times so that there was no net gradient for flow that might influence the contraction pattern because of production of endothelial nitric oxide. 19 The bath was exchanged with 165 or 185 Na + Krebs solution or 40 or 80 mOsm urea solution and allowed to equilibrate for 60 minutes after which another set of pressure steps was imposed. Afterward, the bath was exchanged with Ca 2+ free Krebs solution for 20 minutes, and the passive diameter of the vessel was recorded at each of the different pressures used.
After the experiment, end-systolic and diastolic diameters (ESD and EDD, respectively) were determined for each individual spontaneous contraction at each pressure level. Contraction frequency (FREQ) was computed on a contraction-by-contraction basis, and the following contraction parameters were calculated:
Tone % = MaxD EDD /MaxD *100
Fractional Pump Flow = FREQ*EF (4) MaxD was the maximum passive diameter obtained in Ca
2+
-free Krebs solution at each respective pressure. The average of each of the parameters was determined over each 2 to 3-minute interval at each pressure, and the values were tabulated in Excel to produce the summary graphs.
Data Analysis and Statistics
Data and statistical analysis were performed using GraphPad PRISM Version 7.0. All data passed normality and equal variance tests; therefore, parametric 2-tailed t tests were chosen to compare 2 groups while differences between multiple groups were assessed by ANOVA followed by Dunnett or Bonferroni multiple comparisons test as specified in the figure legends. Values are given as mean±SD, and P<0.05 was considered statistically significant.
Results
Establishment of Models of Salt-Sensitive Hypertension
Here, we applied the same models as those used in a recent study by Nikpey et al 20 and previously by Machnik et al 7 to induce skin salt accumulation and that have been shown to be accompanied by lymphangiogenesis in skin, that is, feeding a HSD 12 and the DOCA-salt model without uninephrectomy. Blood pressure as measured with the tail-cuff method at the initiation of HSD or DOCA treatment (day 0) was not different between rats assigned to LSD, HSD, and DOCA-salt groups (data not shown). Figure 1A shows collected mean arterial pressures for all the rats included in the study, and we observed that HSD as well as DOCA-salt induced an increase in mean blood pressure averaging 18 and 51 mm Hg compared with LSD, respectively. This corresponds well with our own recently published data 20 and with previous reports using the same models but where blood pressure was measured with a catheter in awake animals. 7, 12 In a subset of rats, we investigated whether the HSD and DOCA-salt treatment resulted in salt and fluid accumulation in skin. Skin water content assessed by drying until the weight stabilized tended to be increased in HSD compared with LSD, but the increase was statistically significant only in DOCA-salt rats, averaging 19% ( Figure 1B ). There was, however, a significant increase in Na + content relative to water ( Figure 1C ) as well as Na + content relative to dry weight ( Figure 1D ) in HSD and DOCA-salt treatment compared with the LSD group, in line with corresponding data in own 20 as well as previous experiments with these models. 7, 12 To investigate whether our high-salt models also led to an increased lymphangiogenesis, we stained for LYVE-1 in skin ( Figure 1E ). As shown in Figure 1F , the lymph vessel number was increased in HSD and DOCA-salt-fed rats in agreement with previous studies.
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Salt Accumulation Induces Increased Lymph Flow in Skin
To assess whether the lymphangiogenesis in skin induced by HSD and DOCA-salt treatment had an influence on lymph flow, we used an optical imaging method based on washout of the near-infrared probe Alexa680 bound to albumin. 13 With this method, the rate constant of the washout will reflect lymph flow. Washout curves for LSD, HSD, and DOCA-salt are shown in Figure 2A and the corresponding rate constants for the washout in Figure 2B . The slopes of HSD and DOCA-salt washout curves were significantly different from that of LSD, + content relative to dry weight in LSD, HSD, and DOCA-salt diet. E, Representative ear skin sections showing LYVE (lymphatic vessel endothelial hyaluronan receptor 1)-1+ lymphatic vessels in LSD, HSD, and DOCA-salt fed rats. Scale bar=50 µm. F, LYVE-1+ lymphatic vessels were counted in 5 to 7 consecutive fields per section from 3 rats per group. Also shown mean±SD. *P<0.05, ***P<0.001, ****P<0.0001 when compared with LSD (ANOVA followed by Dunnett multiple comparisons test).
suggesting an increased lymph flow under high-salt conditions (Figure 2A ). Although the average washout of tracer was faster and thus the rate constants for HSD and DOCA-salt were 27% and 33% higher (more negative value), and might indicate a higher lymph flow, particularly for the DOCA-salt group as shown by the P=0.058 when compared with LSD, these rate constants were not significantly different ( Figure 2B ).
To increase the sensitivity of the analysis, and also include the night time in the washout period when the rat is more active, we recorded the tracer remaining in the depot 22 hours after injection ( Figure 2C ). In this analysis, we included all animals that were used in the study, also those from subgroups that were used as controls in the clodronate experiments (see below). Whereas on average 24% of the tracer remained in the LSD group, the corresponding fraction averaged 19% in the HSD as well as the DOCA group, both significantly lower than in the LSD group (P<0.01 for both comparisons; Figure 2C ). This shows that with increased resolution of the tracer washout, we were able to demonstrate an increased lymph flow in both of the groups that accumulated salt.
Lymph Flow in Muscle Increased as Recorded With PET
Recent studies have indicated that Na + appears to accumulate in both skin and skeletal muscle in hypertensive patients. 14 We, therefore, asked whether such accumulation also influenced lymph drainage in muscle. Because photons emitted by fluorescent probes are absorbed in tissues to a higher extent than radionuclides, we decided to develop a PET/CT method to be able to assess lymph flow in the deeper positioned muscle. By labeling HSA with 124 I, we could, as for optical imaging, record washout of radioactive tracer and thereby lymph flow in muscle.
As shown by high-performance liquid chromatography, we made a macromolecular probe that after labeling was inseparable from the native substance and without any free tracer that might have been taken up by the capillaries and thus led to an overestimation of the tracer washout rate ( Figure 3A ). An example of original recordings of tracer washout in 1 rat at different time points is shown in Figure 3B and a summary of tracer washout for LSD and HSD in Figure 3C . The rate constants (k values) for muscle were not different between the LSD and HSD ( Figure 3D ) when recorded in intermittent sessions during daytime. As for skin, we also recorded the tracer remaining 22 hours after injection in muscle. Interestingly, we found a subtle, but statistically significant difference between LSD and HSD, inasmuch as 15% and 12% of the tracer (P<0.05) remained in skeletal muscle 22-hour postinjection ( Figure 3E ), suggesting that the HSD increases lymph flow in muscle as well as in skin.
Extravasation of 125 I-HSA
In a steady-state situation with no fluid accumulation, the net amount of fluid filtered across the capillaries will be taken up and removed by lymphatics. Because we found that the lymph flow was increased in skin and muscle, we estimated the fluid extravasation in paw skin and thigh muscle using the double isotope tracer technique for all groups in skin and for LSD and HSD in muscle. As can be seen from Figure 4 , there was no difference in extravasation in either tissue ( Figure 4A and 4B) . A similar protein extravasation in HSD and LSD indicates that the endothelial barrier is intact in the HSD situation and that the increase in lymph flow in high-salt conditions is not a result of an influence of salt on the endothelial barrier.
Effect of Blocking MPS Cells by Clodronate
Previous studies have shown that depletion of MPS cells with clodronate prevents the lymphangiogenesis induced by salt accumulation and increases the blood pressure. 7, 12 To confirm that skin MPS cells were depleted in response to clodronate in our experiment, we stained with the MPS cell marker CD68 in skin sections from LSD, HSD, and DOCA-salt rats with or without such treatment ( Figure 5A ). CD68+ MPS cells increased significantly in skin after HSD, but not after DOCA-salt diet, while clodronate treatment reduced the number of CD68+ cells below basal levels in all the 3 diet groups ( Figure 5B ). To assess whether such MPS-cell blockage also influenced the drainage of fluid from the tissue, we measured clearance of tracer with optical imaging in skin after clodronate administration in all group of rats ( Figure 5C ). Although the average rate constant, k, after clodronate treatment was slightly higher (less negative) in HSD and DOCA-salt rats indicating a reduced lymph flow, this difference was statistically significant in the DOCA group only ( Figure 5C ).
We then measured the amount of tracer remaining of the injected depot after 22 hours, that is, including an overnight washout period, and found that more tended to remain in the HSD and DOCA-salt rats after clodronate treatment when compared with the corresponding control fraction. The remaining fractions after clodronate were significantly different from their respective controls for HSD and DOCA-salt, whereas clodronate treatment had no effect in the LSD group. This finding suggests that the depletion of MPS cells resulted in a dysfunction of the lymphatics under high-salt conditions and a reduced clearance function ( Figure 5D ).
Increased Contraction of Lymphatics in High-Salt Environment
Based on our finding of an increase in lymph flow in rats with salt accumulation in skin interstitium, we asked whether this affected the contraction properties of the small lymph collecting vessels. To this end, we isolated and cannulated afferent lymph vessels from normal mouse skin ( Figure 6A ), and Figure 6B and 6C. Each downward deflection represents a single contraction lasting 3 to 5 s. P in and P out are the pressures set by the input and output cannulas, respectively, and were equal throughout the pressure step protocol. Lowering pressure in steps from 3 to 0.5 cm H 2 O resulted in a slowing of spontaneous contraction frequency and an increase in contraction amplitude at 1 and 2 cm H 2 O but a decrease in amplitude at 0.5 cm H 2 O; raising pressure from 0.5 to 10 cm H 2 O resulted in an increase in frequency and decrease in amplitude such that only weak contractions were observed at pressures higher than 5 cm H 2 O. These patterns are consistent with those reported previously for lymphatic collectors from both rat mesentery and other peripheral regions of the mouse. 18, 19 Exposure of the vessel to 185 mmol/L Na + Krebs solution produced increases in frequency and slight decreases in amplitude at all pressures ( Figure 6C) .
Results from 5 vessels exposed to both 145, 165, and 185 mmol/L Na + Krebs solutions have been summarized in Figure 6D and 6E and Figure I in the online-only Data Supplement. For contraction frequency and fractional pump flow, there was a dose-dependent effect of Na + in the Krebs buffer solution surrounding the vessel ( Figure 6D and 6E) , whereas for amplitude, ejection fraction, and vessel tone there was no difference between the groups. Replacing the additional Na + with urea to obtain a similar osmolality had no effect on any of the recorded parameters (Figure 6D and 6E; Figure II in the online-only Data Supplement). Therefore, exposure of the adventitia of the collecting vessel to a hypertonic solution that has tonicity in the upper range of what might be expected after HSD and DOCA-salt treatment resulted in increased contraction frequency that was most pronounced at high pressures as well as pump flow at low pressures. An increased pumping may thus be part of the explanation for the observed rise lymph flow.
Discussion
The major question asked in the present study was whether the salt accumulation shown to result in macrophage accumulation and lymphangiogenesis had any influence on lymphatic function. Here, we found that high-salt conditions resulted in an increase in lymph flow that was detectable only after including an overnight recording period. We moreover developed a PET/CT method to assess lymph flow in skeletal muscle and observed that lymph flow was increased after salt exposure in muscle too. Ex vivo studies of isolated afferent collecting vessels suggested that a high interstitial concentration of Na + gave more frequent contractions, without a significant compromise in contraction amplitude, that might contribute to the observed flow increase. The transcapillary extravasation of albumin was unaffected by the HSD treatment, indicating that the capillary barrier was not influenced by the salt accumulation. A significant reduction in lymph flow after depletion of macrophages by clodronate indicates that these cells are involved in the observed lymph flow response. The enhanced tissue fluid clearance suggests that the lymphatics may contribute to long-term regulation of tissue fluid balance during Each downward deflection represents a single contraction lasting 3 to 5 s. P in and P out are the pressures set by the input and output cannulas, respectively, and were equal throughout the pressure step protocol. Lowering pressure in steps from 3 to 0.5 cm H 2 O resulted in a slowing of spontaneous contraction frequency and an increase in contraction amplitude at 1 and 2 cm H 2 O but a decrease in amplitude at 0.5 cm H 2 O; raising pressure from 0.5 to 10 cm H 2 O resulted in an increase in frequency and decrease in amplitude such that only weak contractions were observed at pressures higher than 5 cm H 2 O. Exposure of the vessel to 185 Na + Krebs solution produced increases in frequency and slight decreases in amplitude at all pressures (C). Summary of results from 5 vessels exposed to 145, 165, and 185 mmol Na + Krebs solutions and solutions where additional Na + has been replaced by urea. Values mean±SD. *P<0.05 (ANOVA followed by Bonferroni multiple comparison tests).
salt accumulation by contributing to electrolyte and fluid homeostasis in skin and muscle.
Evaluation of Methods and Limitations
To assess lymph flow in skin, we used a sensitive and minimally invasive optical imaging method that we have validated in a recent article. 13 One limitation about optical imaging is photon absorption in the tissue. This stimulated us to develop a PET/CT-based method that is not limited by tissue depth 21 to be able to record reliably from the deeper structures like muscle that, similarly to skin, has been shown to accumulate Na + in hypertensive patients. 14 To our knowledge, PET/CT has not been used to monitor lymph flow previously but has been applied to visualize inflammation and tumor-induced lymph node lymphangiogenesis by intravenous injection of a PET-probe targeting lymphatic-specific epitopes. 22 Clearly, PET/CT is an expensive and labor-intensive method, but we present a new and valuable alternative for recording of lymph flow that can be used in several species, including mice, when recordings from deeper structures are required.
Our use of mouse afferent lymphatics from skin to determine contraction properties of the vessels in a hyperosmotic environment might be considered as a limitation of the relevance to all the other data obtained from rats. It should be noted though, that mouse and rat lymphatics have been found to respond similarly in comparable experiments ex vivo 18, 19 and in vivo. 23 Importantly, in a recent comprehensive study, it was concluded that peripheral lymph vessels, as studied by us, from mice and rats respond similarly to contraction stimuli. 24 Moreover, in preliminary experiments, we have results indicating that peripheral rat vessels respond similarly as mouse vessels when exposed to high-salt conditions. Together, these studies suggest that the present contraction data obtained from mouse vessels are relevant also for rats. Moreover, these lymph vessel contraction data are also relevant because much of the work having shown a role of skin lymphatics in blood pressure regulation originates from mice.
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Comparison to Previous Studies
In a recent study, Kwon et al 23 have tried to assess lymphatic contractile function in rats and mice after induction of hypertension with HSD. By using indocyanine green, they were able to show dilated vessels having an increased contractility in the HSD animals, a contractility response pointing in the same direction as our ex vivo results. Their contraction frequency response was, however, quite dramatic, amounting to ≈200% after 14 days of HSD in both species. Such an increment is surprising considering the modest augmentation needed to provide for the modest change in lymph flow found in the present study. It is possible that the rather large volume of indocyanine green needed for the imaging of the hindlimb (10 and 50 μL, the amount not specified in the various experiments), volumes shown by us to increase lymph flow, 16 might have influenced these results. The present models for hypertension, HSD and DOCA-salt feeding, are characterized by generation of VEGF-C, which also has a potential effect on contractility of lymphatic collectors. Breslin et al 25 superfused rat mesentery lymphatics with VEGF-C and found an increased lymphatic pumping mediated through VEGFR (vascular endothelial growth factor receptor)-3. Although the dose they chose was based on data from humans, it apparently was sufficient to augment the capillary permeability in the mesenteric circulation. Because the albumin extravasation in skin and muscle was unaltered in high-salt conditions in our experiments, it seems unlikely that VEGF-C contributed to the lymph flow effect that we observed.
Implications of Findings
Ever since the demonstration that HSD induces MPS cell accumulation, VEGF-C secretion and subsequent lymphangiogenesis, 12 a crucial question has been what the functional consequence of such lymphangiogenesis are, adding to the more general question of what lymphangiogenesis achieves. 26 Apparently, both blocking of the MPS-cell accumulation by clodronate during salt loading and inhibiting the lymphatic hyperplasia, 7, 12 as well as curbing the ability for lymphangiogenesis by the use of a VEGF-C receptor trap mouse model 11 or an angiogenesis inhibitor, 27 have resulted in hypertension. These studies suggest that lymphangiogenesis has a role in blood pressure control in high-salt conditions. The question then is whether the lymph capillary network has an integral role in the maintenance of interstitial electrolyte and volume homeostasis as recently proposed. 12 With regard to electrolyte homeostasis, if the lymphatics were to contribute one might think that the concentration of electrolytes and other osmolytes would be higher in lymph draining skin that is hyperosmotic because of salt accumulation. In HSD and DOCA-salt-treated rats, however, the osmolality and electrolyte concentration were equal to those of control LSD rats, 20 showing that there is no gradient between interstitium and lymph. Still, given the same electrolyte concentration in lymph in LSD on the one hand and HSD and DOCA-salt on the other, an increased lymph flow in the highsalt groups would transport more electrolytes from the tissue and thus contribute to clearance of osmolytes and electrolytes from tissues with accumulated salt. This mechanism, possibly assisted by increased lymphatic pumping because of a hyperosmotic interstitium as indicated by our experiments, may contribute to the maintenance of electrolyte homeostasis. Our finding of an increase in lymph flow that was first recognized after long-term observation in a period where the rats are more active thereby suggests that an enhanced clearance of fluid from the tissue is an integrated element of this homeostasis.
There are, indeed, clinical data that support the hypothesis that the lymphatics are influencing disease development. In end-stage renal disease patients undergoing hemodialysis, Dahlmann et al 28 measured Na + in skin and muscle and observed an increase content with age. Interestingly, there was a reduction in VEGF-C with age, and thus an inverse relation to Na + in skin and VEGF-C in plasma. They proposed that the lower VEGF-C levels could reduce the Na + clearance and lead to Na + accumulation in the skin. Even though we do not know whether the reduced VEGF-C results in reduced pumping efficiency, insufficient lymphangiogenesis or reduced lymph flow, these data clearly point to lymphatic function as an important factor in Na + homeostasis and a disease-modulating factor. This factor might be targeted in other conditions characterized by salt accumulation such as chronic kidney disease and hypertension. 14, 28 In spite of significant salt accumulation, the water accumulation was modest. It is therefore likely that the interstitial fluid volume was in steady state at the time of study. The extravasation experiments suggest that the capillary permeability and thereby the integrity of vessel wall was not changed by the high salt intake that has been proposed to induce an inflammatory reaction. 29 With an intact vessel barrier and no (HSD) or limited fluid accumulation (DOCA), we may assume a transcapillary filtration equal to that of lymph flow, and thus a higher filtration when recorded over a longer period involving the night.
To summarize here, we have been able to address the question what lymphangiogenesis achieves 26 in a situation where salt accumulation results in a hyperosmotic interstitium with macrophage accumulation, VEGF-C production, and ensuing lymphangiogenesis. Accumulation of salt resulted in an increase in lymph flow of 26% and 20% from skin and muscle, respectively, and was first recognized after long-term observation. Such an increase is likely the result of a corresponding enhanced filtration of fluid in combination with an increased contraction frequency of lymphatic collectors. Although this increase in flow might seem modest, we must remember that the transport of Na + (and other ions) from these tissues back to the general circulation will increase correspondingly, and suggests that an enhanced clearance of fluid from the tissue is an integrated element of electrolyte homeostasis and a regulatory mechanism working over a long time. These studies point to the importance of lymph flow as a potential disease-modifying factor that might be targeted in other conditions characterized by salt accumulation like chronic kidney disease and hypertension.
